EDWARDS LIFESCIENCES CORP (EW)       87.18  +1.72 (+2.01%)

87.18  +1.72 (+2.01%)

US28176E1082 - Common Stock - After market: 87.26 +0.08 (+0.09%)

EDWARDS LIFESCIENCES CORP87.18

NYSE:EW (10/4/2022, 7:23:54 PM)+1.72 (+2.01%)

After market: 87.26 +0.08 (+0.09%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Health Care Equipment & Supplies
Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend
Overview
Earnings (Last) 07-28 2022-07-28/amc Earnings (Next) 10-26 2022-10-26/amc
Ins Owners 0.16% Inst Owners 175.66%
Market Cap 54.05B Shares 619.94M
PE 38.24 Fwd PE 31.28
Dividend Yield N/A Analysts 81.29
IPO 03-27 2000-03-27

Stock Screener Links

Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

EW Daily chart

Company Profile

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. The company is headquartered in Irvine, California and currently employs 15,700 full-time employees. The company went IPO on 2000-03-27. The firm is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart and Critical Care. The company also develops hemodynamic and noninvasive brain and tissue oxygenation monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including Edwards SAPIEN XT, the Edwards SAPIEN 3, and the Edwards SAPIEN 3 Ultra transcatheter aortic heart valves are used to treat heart valve disease.

Company Info

EDWARDS LIFESCIENCES CORP

One Edwards Way

Irvine CALIFORNIA 92614

P: 19492502500.0

CEO: Michael A. Mussallem

Employees: 15700

Website: https://www.edwards.com

EW News

News Image17 hours ago - FinancialNewsMediaGlobal Laser Therapy Devices Billion Dollar Market Thriving on Growing Demand

Palm Beach, FL – October 4, 2022 – FinancialNewsMedia.com News Commentary –  The laser therapy market has been having a very health growth trend in recent years and is expected to continue through the coming years. Minimally invasive surgical procedures have entered the limelight within the global healthcare space. Incidences of surgical wounds and corresponding […]

News Image17 hours ago - FinancialNewsMedia.comGlobal Laser Therapy Devices Billion Dollar Market Thriving on Growing Demand

/PRNewswire/ -- The laser therapy market has been having a very health growth trend in recent years and is expected to continue through the coming years....

News Image15 days ago - Market News VideoMonday Sector Laggards: Healthcare, Technology & CommunicationsNews Image18 days ago - Edwards Lifesciences CorporationEDWARDS ANNOUNCES SIX-MONTH DATA CONFIRMING TEER AS SAFE AND EFFECTIVE FOR DMR IN FIRST HEAD-TO-HEAD TRIAL

/PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) announced results from CLASP IID, the first randomized controlled trial that directly compares two...

News Image19 days ago - Market News VideoFirst Week of EW May 2023 Options TradingNews Image23 days ago - Edwards Lifesciences CorporationEDWARDS LAUNCHES SAPIEN 3 ULTRA RESILIA VALVE FOLLOWING FDA APPROVAL

/PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates Edwards' breakthrough...

EW Twits

Here you can normally see the latest stock twits on EW, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example